Karin Cecilia Dahllöf

Karin Cecilia Dahllöf

Chief Executive Officer presso MONIVENT AB

65 anni
Health Technology
Consumer Services

Profilo

Karin Cecilia Dahllöf is currently the Chief Executive Officer at Monivent AB, an Independent Director at Boule Diagnostics AB and Bio Vitos Pharma AB, and a Director at Histolab Products AB.
Previously, she worked as a Director-Special Projects at HemoCue AB, Director-Hematology Business Unit at EKF Diagnostics Holdings Plc, and Vice President-Sales & Marketing at CellaVision AB.
She completed her undergraduate degree at the University of Gothenburg.

Posizioni attive di Karin Cecilia Dahllöf

SocietàPosizioneInizio
BOULE DIAGNOSTICS AB Director/Board Member 01/01/2015
MONIVENT AB Chief Executive Officer 01/11/2018
BIO VITOS PHARMA AB Director/Board Member 01/01/2018
Histolab Products AB Director/Board Member -
Tutte le posizioni attive di Karin Cecilia Dahllöf

Precedenti posizioni note di Karin Cecilia Dahllöf

SocietàPosizioneFine
EKF DIAGNOSTICS HOLDINGS PLC Corporate Officer/Principal -
Corporate Officer/Principal -
CELLAVISION AB Sales & Marketing -
Vedi nel dettaglio l'esperienza di Karin Cecilia Dahllöf

Formazione di Karin Cecilia Dahllöf

University of Gothenburg Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Karin Cecilia Dahllöf

Relazioni

41

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
CELLAVISION AB

Health Technology

BOULE DIAGNOSTICS AB

Health Technology

EKF DIAGNOSTICS HOLDINGS PLC

Health Technology

BIO VITOS PHARMA AB

Health Technology

MONIVENT AB

Health Technology

Aziende private2

Health Technology

Histolab Products AB

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Karin Cecilia Dahllöf